پنجشنبه 26 شهریور 1405
[Archive]
دوره 23، شماره 7 - ( 4-1404 )
جلد 23 شماره 7 صفحات 589-587 |
برگشت به فهرست نسخه ها
Ethics code: IR.ARUMS.REC.1399.604
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Salehzadeh F, Mohammadi Kebar Y, Nezhadseifi E. Familial Mediterranean fever and reproductive systems, our experience in two decades: A letter to editor. IJRM 2025; 23 (7) :587-589
URL: http://ijrm.ir/article-1-3483-fa.html
URL: http://ijrm.ir/article-1-3483-fa.html
Familial Mediterranean fever and reproductive systems, our experience in two decades: A letter to editor. International Journal of Reproductive BioMedicine. 1404; 23 (7) :587-589
چکیده: (707 مشاهده)
Due to the chronic nature of familial Mediterranean fever (FMF), there have always been conflicting reports regarding the effect of disease complications such as amyloidosis and its treatment by colchicine on the reproductive system, fertility, and pregnancy (1). The presence of recurring peritonitis and its possibility of intestinal obstruction has led to a secondary effect on the reproductive system and increased risk of infertility and miscarriage. Continuation of colchicine with its potential teratogenic and birth defects, and even premature delivery with the possibility of early miscarriage in case of attacks, are the main challenges in females with FMF. The presumptive side effects of treatment, such as oligospermia and azoospermia, have been a dilemma for males with FMF. Finally, following pregnancy, breastfeeding by the infant, in case of colchicine consumption by the mother, is another issue that needs to be discussed more (1). Here we discuss FMF and its effect on reproductive systems of women, and we share our 2 decades of experience considering this complicated issue. This study included all women with FMF at Bouali Children’s hospital, Ardabil and the FMF Registration Center in Iran (http://WWW.FMFIRAN.IR). Nearly 600 patients were enrolled in this study; all patients had FMF according to Tel-Hashomer clinical criteria and/or based on MEFV gene mutation analysis. In 2 decades, 11 female patients with FMF, phenotypically and or genetically confirmed, without renal or amyloidosis-related complications of FMF, decided to become pregnant. All of them were advised to continue taking colchicine (1–2 mg daily) throughout their pregnancy and lactation periods; any dose reduction of colchicine was not suggested. All were in their active reproductive age of life, and most were primipara. 3 women showed M694V mutations as homozygotes, one woman had M680I homozygotes, and 5 women had compound heterozygotes, and the rest were heterozygote mutations.
نوع مطالعه: Letter to Editor |
فهرست منابع
1. Yanmaz MN, Özcan AJ, Savan K. The impact of familial Mediterranean fever on reproductive system. Clin Rheumatol 2014; 33: 1385-1388. [DOI:10.1007/s10067-014-2709-9] [PMID]
2. Parlar K, Azman FN, Sıcakyüz SL, Riaoglu M, Azman E, Yzbasioglu MB, et al. Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications. Intern Emerg Med 2025; 20: 797-803. [DOI:10.1007/s11739-025-03881-y] [PMID] [PMCID]
3. Er O, Ugurlu S. Fertilization, reproductive system, and pregnancy in familial Mediterranean fever: Clinical state of art. Modern Rheumatol 2024; 34: 265-271. [DOI:10.1093/mr/road067] [PMID]
4. Atas N, Armagan B, Bodakci E, Satis H, Sari A, Bilge NSY, et al. Familial Mediterranean fever-associated infertility and underlying factors. Clin Rheumatol 2020; 39: 255-261. [DOI:10.1007/s10067-019-04773-1] [PMID]
5. Sotskiy PO, Sotskaya OL, Hayrapetyan HS, Sarkisian TF, Yeghiazaryan AR, Atoyan SA, et al. Infertility causes and pregnancy outcome in patients with familial Mediterranean fever and controls. J Rheumatol 2021; 48: 608-614. [DOI:10.3899/jrheum.200574] [PMID]
6. Ferreira NR, Buoniconti A. Trisomy after colchicine therapy. Lancet 1968; 292: 1304. [DOI:10.1016/S0140-6736(68)91805-9] [PMID]
7. Ben‐Chetrit E, Ben‐Chetrit A, Berkun Y, Ben‐Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: Is amniocentesis justified? Arthritis Care Res 2010; 62: 143-148. [DOI:10.1002/acr.20061] [PMID]
8. Yurdakul FG, Bodur H, Çay HF, Uçar Ü, Keskin Y, Sargin B, et al. Familial Mediterranean fever: Perspective on female fertility and disease course in pregnancy from a multicenter nationwide network. Rheumatol Int 2024; 44: 2117-2127. [DOI:10.1007/s00296-023-05436-w] [PMID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
